Abstract
Drugs that bind readily to a tissue may differ markedly in their ability to produce an effect. In other words, they differ in efficacy or in intrinsic activity. We do not know the reason for these differences; in fact, we do not know very much about the sequence of events between binding and effect. A reasonable explanation would seem to be access to the receptor. Clearly, if the drug molecule cannot arrive at the receptor, then no effect is possible. However, even when access to the receptor is not limited, the effect may not temporally follow the binding. For example, if acetylcholine is administered to a tissue, the effect can rise to a peak and then fall to some lower level, even though the concentration at the receptor is still apparently rising. As a specific example, we mention the work of Lullman and Ziegler,33 who studied the time course of uptake of carbachol by the guinea pig atria and the time course of the effect, decreased contractile force. The time courses of effect and concentration were very different. The effect reached its final value in 2–3 min, whereas the uptake was still in progress even after 30 min. These are just two examples, but there are numerous others which suggest a temporal dependence in the concentration-effect relationship. Thus, access to the receptors is not a general explanation for differences in the efficacy. Furthermore, binding to the tissue may bear no relation to a drug’s ability to produce an effect.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akera, T.: Science, 195: 569, 1977.
Archer, J. A., Gorden, P., and Roth, J.: J. Clin. Invest., 55: 166, 1975.
Bar, R. S., and Roth, J.: Arch. Intern. Med., 137: 474, 1977.
Bar, R. S., Gorden, P., and Roth, J: J. Clin. Invest., 58: 1123, 1976.
Barsoum, G. S., and Gaddum, J. H.: J. Physiol. (London), 85: 1, 1935.
Blasig, J., Hollt, V., Herz, A., and Paschelke, G.: Psychopharmacologia, 46: 41, 1976.
Cantoni, G. L., and Eastman, G.: J. Pharmacol. Exp. Therap., 87: 392, 1946.
Cochin, J.: Fed. Proc., 29: 19, 1970.
Cochin, J. In Drug Addiction, Experimental Pharmacology. ( Singh, J. M., Miller, L. and Lai, H. eds.) New York, Futura Publishing Co., 1972, p. 365.
Cowan, A., Tallarida, R. J., Maslow, J., and Adler, M. W.: Proc. 7th Int. Cong. Pharmacology, Paris, 1978, Abstracts, p. 168.
Cox, B. M.: Br. J. Pharmacol., 62: 387P, 1978.
Cull-Candy, S. G., Miledi, R., and Trautmann, A.: Nature, 271: 74, 1978.
Del Castillo, J., and Katz, B.: Proc. R. Soc. London, Ser., B 146: 369. 1957.
Dum, J., Meyer, G., Hollt, V., Herz. A., and Catlin, D. H.: Eur. J. Pharmacol., 46: 165, 1977.
Furchgott, R. F.: Fed. Proc., 37: 115, 1978.
Gero, A.: Arch. Int. Pharmacodyn., 206: 41, 1973.
Gero, A.: J. Mol. Medicine, 7: 161, 1976.
Giachetti, A., and Shore, P. A.: Life Sci., 21: 89, 1978.
Goldstein, A., Lowney, K. I., and Pal, B. K.: Proc. Natl. Acad. Sci. U.S.A., 68: 1742, 1971.
Guldberg, C. M., and Waage, P.: In Physical Chemistry (W. J. Moore, ed.), 4th ed. Englewood Cliffs, N.J., Prentice-Hall, 1972, p. 282.
Hayashi, G., and Takemori, A. E.: Eur. J. Pharmacol., 76: 63. 1971.
Hogben, C. A., Tocco, D. J., Brodie, B. B., and Schanker, L. S.: J. Pharmacol. Exp. Therap., 725: 275, 1959.
Höllt, V., and Herz, A.: Fed. Proc., 37: 158, 1978.
Höllt, V., Dum, J., Bläsig, J., Schubert, P., and Herz, A.: Life Sei., 16: 1823, 1975.
Hulme, E. C., Birdsall, N. J. M., Burgen, A. S. V., and Mehta, P.: Mol. Pharmacol., 14: 731, 1978.
Janis, R. A., and Triggle, D. J.: J. Pharmacol. Exp. Therap., 24: 602, 1972.
Katz, B., and Thesleff, S.: J. Physiol. (London), 138: 63, 1957.
Kebabian, J. W., and Calne, D. B.: Nature 277: 93, 1979.
Koshland, D. E.: Fed. Proc., 23: 719, 1964.
La Du, B. N., Mandel, H. G., and Way, E. L.: Fundamentals of Drug Metabolism and Disposition. Baltimore, Williams and Wilkins, 1971.
Lee, T., Seeman, P., Rajput, A., Farley, I. J., and Hornykiewicz, O.: Nature, 275: 59, 1978.
Loh, H. L., Law, P. Y., Ostwald, T., Cho, T. M., and Way, E. L.: Fed. Proc., 37: 147, 1978.
Lullman, H., and Ziegler, A.: Naunyn-Schmiedebergs Arch. Pharmacol., 280: 1, 1973.
Martin, W. R., Eades, C. G., Thompson, J. A., Huppier, R. E., and Gilbert, P. E.: J. Pharmacol. Exp. Therap., 797: 517, 1976.
McGilliard, K. L., Tulunay, F. C., and Takemori, A. E.: In Opiates and Endogenous Opioid Peptides (H. W. Kosterlitz, ed.) Amsterdam, North Holland Publishing Co., 1976, p. 281.
McGilliard, K., and Takemori, A. E.: J. Pharmacol. Exp. Ther., 207: 884, 1978.
MacNab, M. W. Ph.D. Thesis, Temple University Medical School, Philadelphia, Pa., 1974.
Möhler, H., and Okada, T.: Science, 795: 849, 1977.
Mollering, R. C., and Swartz, M. N.: Drug Therapy, 4: 85, 1976.
Neu, H. C.: Southern Med. J., 70 (Supp. 1 ): 14, 1977.
Olefsky, J. M.: Diabetes, 25: 1154, 1976.
Olefsky, J. M., and Reaven, G. M.: J. Clin. Invest., 54: 1323, 1975.
Pert, C. B., and Snyder, S. H.: Science, 779: 1011, 1973.
Rane, A., Wilkinson, G. R., and Shand, D. G.: J. Pharmacol. Exp. Therap., 200: 420, 1977.
Rang, H. P., and Ritter, J. M.: Mol. Pharmacol., 6: 357, 1970.
Riggs, D. S.: The Mathematical Approach to Physiological Problems. Baltimore, Williams and Wilkins, 1963.
Robinson, G. N., and Sutherland, R.: Br. J. Pharmacol., 25: 638, 1965.
Schanker, L. S.: Ann. Rev. Pharmacol., 7: 29, 1961.
Shen, J. W., and Way, E. L.: Life Sci., 16: 71, 1975.
Simon, E. J., and Hiller, J. M.: Ann. Rev. Pharmacol. Toxicol., 75: 371, 1978.
Simon, E. J., and Hiller, J. M.: Fed. Proc., 37: 141, 1978.
Smits, S. E., and Takemori, A. E.: Br. J. Pharmacol., 39: 627, 1970.
Stahl, K. D., Van Bever, W., Janssen, P., and Simon, E. J.: Eur. J. Pharmacol., 46: 199, 1977.
Szekely, J. I., Dunai-Kovacs, Z., Miglecz, E., Ronai, A. Z., and Bajusz, S.: J. Pharmacol. Exp. Ther., 207: 878, 1978.
Takemori, A. E.: In Narcotic Antagonists. M. C. Braude, L. S. Harris, E. L. May, J. P. Smith, and J. E. Villarreal, eds. Advances in Biochemical Psychopharmacology, 8, New York, Raven Press, 1974, p. 335.
Tallarida, R. J., Cowan, A., and Adler, M. W.: Life Sciences, 25: 637, 1979.
Tallarida, R. J., Harakal, C., Rusy, B. F., and Sevy, R. W.: Currents in Modern Biol., 2: 249, 1968.
Tallarida, R. J., Harakal, C., Maslow, J., Geller, E. B., and Adler, M. W.: J. Pharmacol. Exp. Ther., 206: 38, 1978.
Terenius, L.: Acta Pharmacol. Toxicol., 32: 317, 1973.
Tsai, B. S., and Lefkowitz, R. J.: J. Pharmacol. Exp. Therap., 204: 606, 1978.
Tulunay, F. C.: In Characteristics and Function of Opioids (G. M. Van Ree, and L. Terenius, eds.) Amsterdam, Elsevier-North Holland, 1978, p. 495.
Wagner, J. G.: Biopharmaceutics and Relevant Pharmacokinetics. Hamilton, III., 1971. Drug Intelligence Publications, 1971.
Waud, D. R.: Pharmacol. Rev., 20: 49, 1968.
Wilkinson, G. R., and Schenker, S.: Biochem. Pharmacol., 25: 2675, 1976.
Wohl, A. J., Hausler, L. M., and Roth, F. E.: J. Pharmacol. Exp. Therap., 162: 109, 1968.
Yaksh, T. L., and Rudy, T. A.: J. Pharmacol. Exp. Therap., 202: 411, 1977.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Tallarida, R.J., Jacob, L.S. (1979). Drug Binding and Drug Effect. In: The Dose—Response Relation in Pharmacology. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-6265-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4684-6265-4_5
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-6267-8
Online ISBN: 978-1-4684-6265-4
eBook Packages: Springer Book Archive